Blauvelt, Andrew, Richard G. Langley, Ketty Peris, Juan Francisco Silvestre, Norito Katoh, Marie Tauber, Andreas Pinter, Mahreen Ameen, Melinda Gooderham, Christian Bjerregård Øland, Ann-Marie Tindberg, Le Gjerum, and Kristian Reich. “Continuous Tralokinumab Treatment over 4 Years in Adults With Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s376. Accessed July 3, 2024. https://jofskin.org/index.php/skin/article/view/2679.